Financials MDxHealth SA

Equities

MDXH

BE0974461940

Biotechnology & Medical Research

Market Closed - Nasdaq 03:59:53 2024-07-19 pm EDT 5-day change 1st Jan Change
2.8 USD -1.06% Intraday chart for MDxHealth SA +0.36% -28.93%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 69.42 74.48 143.6 0.0153 97.41 70.93 - -
Enterprise Value (EV) 1 69.42 74.48 143.6 0.0153 97.41 70.93 70.93 70.93
P/E ratio -1.59 x - - - -2.37 x -2.78 x -4.17 x -7.57 x
Yield - - - - - - - -
Capitalization / Revenue 6.41 x 4.87 x 7.17 x 0 x 1.51 x 0.9 x 0.79 x 0.68 x
EV / Revenue 6.41 x 4.87 x 7.17 x 0 x 1.51 x 0.9 x 0.79 x 0.68 x
EV / EBITDA -2.54 x -3.78 x -6.69 x -0 x -5.19 x -6.04 x -38.2 x 10.5 x
EV / FCF - -4.34 x - - -4 x -4.26 x -7.89 x 84.1 x
FCF Yield - -23% - - -25% -23.5% -12.7% 1.19%
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 7,053 9,069 15,597 16,288 27,288 27,288 - -
Reference price 2 11.00 10.10 10.40 0.001000 3.940 2.800 2.800 2.800
Announcement Date 2/26/20 3/3/21 3/2/22 3/8/23 3/6/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 10.83 15.29 20.05 35.07 64.39 78.5 89.88 104.6
EBITDA 1 -27.28 -19.71 -21.46 -31.23 -18.78 -11.74 -1.858 6.739
EBIT 1 -30.42 - -24.2 -35.87 -25.07 -18.31 -8.483 0.032
Operating Margin -280.79% - -120.69% -102.28% -38.93% -23.32% -9.44% 0.03%
Earnings before Tax (EBT) 1 -40.15 - - - -39.53 -27.46 -19.52 -12.64
Net income 1 -39.62 - -26.15 -41.69 -39.54 -26.03 -17.52 -9.706
Net margin -365.72% - -130.41% -118.86% -61.4% -33.16% -19.49% -9.28%
EPS 2 -6.900 - - - -1.660 -1.008 -0.6720 -0.3700
Free Cash Flow 1 - -17.16 - - -24.32 -16.67 -8.988 0.843
FCF margin - -112.22% - - -37.78% -21.23% -10% 0.81%
FCF Conversion (EBITDA) - - - - - - - 12.51%
FCF Conversion (Net income) - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 2/26/20 3/3/21 3/2/22 3/8/23 3/6/24 - - -
1EUR in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2020 S1 2021 S1 2021 Q3 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 8.355 - 5.075 5.793 6.926 11.15 12.2 13.52 15.43 18.07 17.79 18.55 19.48 19.86 20.5 20.92
EBITDA 1 -9.634 - -5.934 -7.268 -8.384 -7.944 -10.13 -6.513 -5.499 -2.35 -4.333 -4.242 -3.094 -1.884 -2.242 -1.901
EBIT 1 -10.98 - -6.598 -7.45 -9.202 -8.135 -12.05 -8.018 -7.136 -4.259 -5.784 -6.176 -4.821 -3.97 -3.926 -3.51
Operating Margin -131.46% - -130% -128.59% -132.86% -72.99% -98.8% -59.3% -46.24% -23.57% -32.51% -33.3% -24.75% -19.99% -19.15% -16.78%
Earnings before Tax (EBT) 1 - - - -7.847 -9.866 - - -10.77 -9.793 -9.38 -9.833 -7.959 -7.217 -6.346 -6.348 -6.164
Net income 1 - -11.3 -7.032 -7.847 -9.867 - -16.4 -10.77 -9.793 -9.38 -9.833 -7.959 -7.063 -6.192 -6.194 -6.01
Net margin - - -138.55% -135.44% -142.46% - -134.41% -79.65% -63.46% -51.91% -55.26% -42.91% -36.26% -31.18% -30.22% -28.73%
EPS 2 - - - - - - - - - - -0.3900 -0.3100 -0.2650 -0.2300 -0.2275 -0.2225
Dividend per Share - - - - - - - - - - - - - - - -
Announcement Date 8/26/20 9/16/21 1/20/23 4/27/22 8/25/22 10/27/22 3/8/23 5/15/23 8/23/23 11/8/23 3/6/24 5/1/24 - - - -
1EUR in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 - -17.2 - - -24.3 -16.7 -8.99 0.84
ROE (net income / shareholders' equity) - - - - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share - - - - - - - -
Cash Flow per Share - - - - - - - -
Capex 1 0.07 0.45 - - 4.6 5.24 4.49 3.65
Capex / Sales 0.62% 2.92% - - 7.15% 6.68% 5% 3.49%
Announcement Date 2/26/20 3/3/21 3/2/22 3/8/23 3/6/24 - - -
1EUR in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
2.83 USD
Average target price
7.25 USD
Spread / Average Target
+156.18%
Consensus
  1. Stock Market
  2. Equities
  3. MDXH Stock
  4. Financials MDxHealth SA